Abstract
Novel functionalized 2-amino-4-(4-oxo-4H-chromen-3-yl)-5-(2,2,2-trifluoroacetyl)-6-(trifluoromethyl)-4H-pyrans and 2-amino-4-(4-oxo-4H-chromen-3-yl)-5-(thiophene-2-carbonyl)-6-(trifluoromethyl)-4H-pyrans have been synthesized by one-pot three-component reaction of 4-oxo-4H-chromene-3-carbaldehyde with three active methylene cyanoacetic acid derivatives and 1,1,1,5,5,5-hexafluoropentane-2,4-dione or 1,1,1-trifluoro-5-(thiophen-2-yl)pentane-2,4-dione in distilled water at 60–70°C without a catalyst. The described methodology displayed excellent yields and simple workup procedure. The synthesized compounds were assessed for their in vitro anticancer activity against human breast cancer (MCF-7), liver cancer (HepG-2), and colon cancer cell lines (HCT-116). One of the compounds, 2-amino-4-(4-oxo-4H-chromen-3-yl)-5-(2,2,2-trifluoroacetyl)-6-(trifluoromethyl)-4H-pyran-3-carbonitrile, exhibited excellent anticancer activity versus all tested cancer cell lines with IC50 values ranging from 0.7 to 1.4 μg/mL.
Similar content being viewed by others
REFERENCES
Malesev, D. and Kuntic, V., J. Serb. Chem. Soc., 2007, vol. 72, p. 921. https://doi.org/10.2298/jsc0710921m
Horton, D.A., Bourne, G.T., and Smythe, M.L., Chem. Rev., 2003, vol. 103, p. 893. https://doi.org/10.1021/cr020033s
Gaspar, A., Matos, M.J., Garrido, J., Uriarte, E., and Borges, F., Chem. Rev., 2014, vol. 114, p. 4960. https://doi.org/10.1021/cr400265z
Keri, R.S., Budagumpi, S., Pai, R.K., and Balakrishna, R.G., Eur. J. Med. Chem., 2014, vol. 78, p. 340. https://doi.org/10.1016/j.ejmech.2014.03.047
Pratap, R. and Ram, V.J., Tetrahedron, 2017, vol. 73, p. 2529. https://doi.org/10.1016/j.tet.2017.02.028
Arbabi, H.A., Soltani, S.S., Salehi, H., Rezazadeh, S., Zonouzi, A., and Toosibashi, M., J. Chem. Res., 2018, vol. 42, p. 68. https://doi.org/10.3184/174751918x15177611816526
Ramtekkar, R., Kumarvel, K., Vasuki, G., Sekar, K., and Krishna, R., Lett. Drug Des. Discovery, 2009, vol. 6, p. 579. https://doi.org/10.2174/157018009789353455
Batran, R.Z., Dawood, D.H., El-Seginy, S.A., Maher, T.J., Gugnani, K.S., and Rondon-Ortiz, A.N., Bioorg. Chem., 2017, vol. 75, p. 274. https://doi.org/10.1016/j.bioorg.2017.09.017
Ouf, N.H., Selim, Y.A., Sakran, M.I., and Badr Eldin, A.S., Med. Chem. Res., 2014, vol. 23, p. 1180. https://doi.org/10.1007/s00044-013-0724-z
Solovyev, P.A., Fesenko, A.A., and Shutalev, A.D., J. Fluorine Chem., 2016, vol. 182, p. 28. https://doi.org/10.1016/j.jfluchem.2015.11.008
Nenajdenko, V., Fluorine in Heterocyclic Chemistry: 5-Membered Heterocycles and Macrocycles, Nenajdenko, V., Ed., New York: Springer, 2014, vol. 1. https://doi.org/10.1007/978-3-319-04346-3
Joule, J.A., Prog. Heterocycl. Chem., 2020, vol. 31, p. 117. https://doi.org/10.1016/B978-0-12-819962-6.00005-1
Singla, N., Singh, G., Bhatia, R., Kumar, A., Kaur, R., and Kaur, S., ChemistrySelect, 2020, vol. 5, p. 3835. https://doi.org/10.1002/slct.202000191
Rahmati, A. and Pashmforoush, N., J. Iran. Chem. Soc., 2015, vol. 12, p. 993. https://doi.org/10.1007/s13738-014-0562-z
Shekouhya, M. and Khalafi-Nezhad, A., Green Chem., 2015, vol. 17, p. 4815. https://doi.org/10.1039/c5gc01448d
Ali, T.E., Ali, M.M., Abdel-Kariem, S.M., and Ahmed, M.M., Synth. Commun., 2017, vol. 47, p. 1458. https://doi.org/10.1080/00397911.2017.1332224
Ali, T.E., Assiri, M.A., El-Shaaer, H.M., Fouda, A.M., Hassan, M.M., and Hassanin, N.M., Heterocycles, 2019, vol. 98, p. 681. https://doi.org/10.3987/COM-19-14062
Ali, T.E., Assiri, M.A., Hassanin, N.M., Yahia, I.S., and Hussien, M.S.A., J. Heterocycl. Chem., 2019, vol. 56, p. 1684. https://doi.org/10.1002/jhet.3550
Assiri, M.A., Ali, T.E., Ibrahim, M.A., Badran, A., and Yahia, I.S., Polycyclic Aromat. Compd., 2021, vol 41, p. 1357. https://doi.org/10.1080/10406638.2019.1678181
Ali, T.E., Assiri, M.A., Ibrahim, M.A., and Yahia, I.S., Russ. J. Org. Chem., 2020, vol. 56, p. 845. https://doi.org/10.1134/S1070428020050188
Firouzabadi, H., Iranpoor, N., and Gholinejad, M., Tetrahedron, 2009, vol. 65, p. 7079. https://doi.org/10.1016/j.tet.2009.06.081
Elinson, M.N., Nasybullin, R.F., Ryzhkov, F.V., and Egorov, M.P., C. R. Chim., 2014, vol. 17, p. 437. https://doi.org/10.1016/j.crci.2013.08.002
Wang, G., Chen, M., Qiu, J., Xie, Z., and Cao, A., Bioorg. Med. Chem. Lett., 2018, vol. 28, pp. 113. https://doi.org/10.1016/j.bmcl.2017.11.047
Sosnovskikh, V.Y. and Rgashev, I.R.A., Tetrahedron Lett., 2007, vol. 48, p. 7436. https://doi.org/10.1016/j.tetlet.2007.08.078
Abd El Aleem, M. and El-Remaily, A.A., Tetrahedron, 2014, vol. 70, p. 2971. https://doi.org/10.1016/j.tet.2014.03.024
Zhang, Z., Han, J., and Zhu, S., Tetrahedron, 2011, vol. 67, p. 8496. https://doi.org/10.1016/j.tet.2011.09.007
Marjani, A.P., Khalafy, J., Arlan, F.M., and Eyni, E., Arkivoc, 2019, vol. 2019, part (v), p. 1. https://doi.org/10.24820/ark.5550190.p010.705
Oma, A. and Ablajan, K., Green Chem. Lett. Rev., 2019, vol. 12, p. 1. https://doi.org/10.1080/17518253.2018.1556744
Skehan, P., Storeng, R., Scudiero, D., Monks, A., McMahon, J., Vistica, D., Warren, J.T., Bokesch, H., Kenney, S., and Boyd, M.R., J. Natl. Cancer Inst., 1990, vol. 82, p. 1107. https://doi.org/10.1093/jnci/82.13.1107
Funding
The authors extend their appreciation to the Deanship of Scientific Research at King Khalid University for funding this work through research groups program under grant number RGP.2/8/43.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Ali, T.E., Assiri, M.A., Shati, A.A. et al. One-Pot Three-Component Synthesis of a Series of 2-Amino-4-(4-oxo-4H-chromen-3-yl)-5-(2,2,2-trifluoroacetyl)-6-(trifluoromethyl)-4H-pyrans and 2-Amino-4-(4-oxo-4H-chromen-3-yl)-5-(thiophene-2-carbonyl)-6-(trifluoromethyl)-4H-pyrans as Promising Anticancer Agents. Russ J Org Chem 58, 584–591 (2022). https://doi.org/10.1134/S1070428022040170
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S1070428022040170